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Abstract 
Along the pathway traced by few recent contribution that attempt to identify the causal effect of social 
capital on health, this paper analyzes whether individual social capital reduces the probability of 
experiencing 11 long-lasting and chronic diseases. The empirical problems related to reverse causation 
and unobserved heterogeneity are addressed by means of a procedure that exploits the within-individual 
variation between the timings of first occurrence of the 11 diseases considered. Estimates indicate that 
the probability of occurrence is on average 14 to 18 percent lower among individuals reporting to “trust 
most of the other people”. This result is robust to two alternative specifications as well as the inclusion or 
omission of individual controls. 
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1. Introduction 
Among the socio-economic determinants of health, a growing attention is being devoted to the 
role of social capital. Many analysis have found a strong positive association between social 
capital and individual health (see Islam et al., 2006, for an extensive review) and the discussion 
about the pathways of this relationship is mounting (Folland et al., 2012).  
Health economics and public health literature suggest several potential pathways for the 
influence of social capital on health. First, social capital may expand the informational resources 
available to individuals, allowing a faster and more intense circulation of health relevant 
information (Scheffler and Brown, 2008). Second, social capital favors the formation of informal 
networks and safety nets which provide mutual insurance to its members in case of health 
shocks (Murgai et al., 2002). Third, social capital may increase the political weight of a 
community making easier to obtain more and better public goods and social welfare programs 
(Kawachi and Kennedy, 1997). Fourth, social capital, by increasing the quality and the utility of 
future life,  could discourage unhealthy behaviors, such as smoking, drinking or mis-nutrition 
(Folland, 2006). All pathways are justified and motivated by the fundamental characteristic of 
social capital of favoring cooperation within communities. 
This paper investigates whether social capital benefits individual health, by exploiting rather 
detailed information about individual health condition and individual social capital included in 
the British Household Panel Survey between 1999 and 2008. For the first time, this paper 
investigates the influence of social capital on the likelihood of specific diseases rather than on 
self-reported general health (or analogous indicators) making possible to tell apart whether 
social capital does influence “true” health or just the way individuals assess and report their 
“true” health (Bailis et al. 2003; Jylhä 2009, 2010; Huisman and Deeg, 2010). Indeed, self-
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reported health has been shown to be sensitive to changes in objective health conditions, such 
as the occurrence of a disease or the emergence of new symptoms, but to reflect also the 
individual prior (self-concept) on own health (Bailis et al., 2003). In particular, social factors could 
alter the way individuals assess and report their own health status (Rocco et al., 2013).  
The empirical identification of the effect of social capital on health is problematic, because social 
capital is likely endogenous (Durlauf and Fafchampes, 2005). Building over few recent 
contribution that have attempted to identify the causal effect of social capital beyond simple 
associations, this paper innovates  because it addresses two empirical problems, reverse 
causation and unobserved heterogeneity, by following an empirical strategy previously 
overlooked, inspired to duration analysis but quite specific. Reverse causation refers to the 
circular relationship likely to exist between social capital and health: indeed, not only social 
capital influences health but also the viceversa can be true. Unobserved heterogeneity, refers 
to the probable omission from the model of relevant and often unobservable characteristics, 
which can influence both social capital and health, such as individual preferences  and attitudes. 
Both problems are responsible for unpredictable bias in the estimates obtained by simple 
regression models.  
The identification strategy exploits within-individual variation in the timing of occurrence of 11 
long-lasting and chronic diseases, both physical and mental2. The occurrence of each disease 
and the level of social capital reported before this occurrence form a switching point. Data are 
rearranged to obtain 11 switching points, one for each diseases, for all individuals. The empirical 
analysis is then conducted on the resulting dataset of switching points. As social capital is pre-
determined at any switching point by construction, possible feedbacks from health conditions 
to social capital are ruled out. Moreover, since diseases occur at different times, the level of 
individual social capital varies within-individual across switching points. This variation allows to 
control for any time-invariant individual heterogeneity, such as preferences, family background 
and inherited culture by means of a standard individual fixed effect estimator.  The effect of 
time-varying shocks is directly accounted for by a number of individual controls.     
Results indicate that individuals rich of social capital, are on average 14 to 18 percent less likely 
to experience a disease, compared to individuals poor of social capital. This result is robust to 
two alternative specifications as well as  the inclusion or omission of individual socio-economic 
controls. 
                                                            
2 In duration analysis this would be the timing of transition from one state to another. 
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The remaining of the paper is organized as follows: the definition of social capital adopted in this 
paper is justified in section 2; the relevant literature is reviewed in section 3;  data are briefly 
described in section 4; the identification strategy is discussed in detail in section 5; results are 
reported in section 6 and finally section 7 concludes. 
     
2. Definition of Social Capital 
The concept of social capital has gained wide acceptance in social sciences and, more recently, 
in economics, where it has been used to explain economic growth (Knack and Keefer, 1997), size 
of firms (La Porta et al., 1997), institution’s design and performance (Djankov et al., 2003), 
financial development (Guiso, Sapienza, and Zingales, 2004, 2008b), crime (Glaeser, Sacerdote, 
and Scheinkman, 1995), the power of the family (Alesina and Giuliano, 2007), innovation 
(Fountain, 1997), and the spread of secondary education (Goldin and Katz, 2001). 
The term social capital is often traced back to the work of the sociologist Bourdieu (1977), but it 
gained popularity in the Nineties, mostly owing to Coleman (1990) and Putnam (1993). Though 
largely used, the concept is contested at both conceptual and measurement level. On the one 
hand, social capital has been conceptualized as a group attribute, i.e. as a property of the 
organization or the community, as opposed to a characteristic of the individual members3. On 
the other hand, the so called “network school” defines social capital as both an individual 
attribute and a property of the social network4.   
Social capital has generally been considered as a multi-faceted object and consequently the 
precise boundaries of the concept are still disputed. Quite differently from this tradition, Guiso 
et al. (2008a, 2011) have recently proposed a more clear-cut definition. They convincingly define 
social capital as an individual belief about others’ willingness to cooperate. When defined in this 
way, social capital can be properly considered a form of capital, that can be accumulated, 
transferred and which returns accrue to its owner (in so doing answering to the well known 
Solow’s critique – Solow, 1995). Indeed, beliefs are individual and vary across people, they can 
be updated as far as new information is acquired by means of social interactions (accumulation 
or de-cumulation of social capital) and can be transmitted from parents to children (transfer of 
social capital). Moreover, beliefs are probabilities and thus they have a well defined and 
undisputed metric. Last but not least, defining social capital as a belief avoids the often arising 
                                                            
3 Examples are social norms, sanctions, values and traditions that display their effects regardless of 
individuals’ adhesion (Kawachi and Berkman, 2000). 
4 Examples are social support, information channels, social credentials, trust (Kawachi et al., 2008) 
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confusion between social capital and some of its outcomes such as the quantity/quality of social 
relations, or involvement in social organizations, and makes social capital clearly distinct from 
human capital because its returns are contingent on the norms and beliefs of other community 
members. 5  
Rather than giving a proper account of the quite long list of social capital definitions appeared 
in the literature and pursuing an ecumenical approach trying to reconcile the multiple aspects 
of social capital, this paper grounds exclusively on Guiso et al. (2008a, 2011)’s definition and 
adopts the indicator (available in BHPS data) that most closely fits with this definition, i.e. 
generalized trust6. This approach has the advantage of simplifying the analysis and the 
interpretation of the results, since the object of interest is much more focused. Of course, the 
cost is that of losing results’ richness and variety compared to an analysis dealing with a multi-
faceted concept. 
3. Literature 
Beside a large and bourgeoning literature that indicates social capital as a key ingredient for 
economic growth, financial development and institutions’ effectiveness, a number of empirical 
papers have estimated reduced form models to show that communities and individuals richer 
in social capital enjoy better health. Several authors (Cooper et al. (1999), Lochner et al. (1999), 
Macinko and Starfield (2001) and Muntaner et al. (2001)) offer reviews of the empirical 
literature on social capital and health. A very complete survey is that of Islam et al. (2006). Most 
studies adopt multilevel estimators and look only at the association between health and 
alternative measures of social capital, either at the individual or at the community level or both. 
Typically these studies estimate reduced form models. Among many others, Veenstra (2000),  
Petrou and Kupek (2008), Fujisawa et al. (2009) and Snelgrove et al. (2009)7 focus on a single 
country, taking into account several possible measures of social capital. Giordano and Lindstrom 
(2010) uses BHPS to analyze how over-time variations in social capital, between 1999 and 2005, 
are associated with variations in self-reported health and find a positive relation between social 
capital  and good general health. Giordano and Lindstrom (2011) again use BHPS and find a 
positive association between generalized trust and psychological health. Brunner (1997), 
                                                            
5 Taking one of the usual distinctions proposed in the literature, this definition considers social capital as 
a cognitive object (rather than structural). 
6 Generalized trust is defined over the answer that individuals provide to questions of the kind “Generally 
speaking, would you say that most people can be trusted?” alike to that originally included in the Value 
Social Survey. Thus generalized trust is an individual belief about the likelihood that other people are 
cooperative or instead adopt opportunistic behaviors.    
7 Snelgrove et al. (2009) look at the UK and use BHPS. 
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Brunner and Marmot (1999), Shkolnikova et al. (2009) find that lack of social support may 
increase the risk of heart diseases, susceptibility to infection, diabetes, high blood pressure and 
high levels of cortisol.  
Poortinga (2006) and Mansyura et al. (2008) pool many countries and estimate the effect of 
individual and community level social capital, by means of multilevel methods. Both find that 
only the former is significant.  
Most analysis report associations. Thus the estimated effect of social capital cannot be 
considered causal, since social capital is likely to be endogenous, as forcefully shown by Durlauf 
and Fafchamps (2005). The causal impact of social capital on individual health has been assessed 
in several recent papers (Rocco et al. 2013, d’Hombres et al., 2010; Sirven and Debrand, 2008; 
Folland, 2007; Scheffler, Brown and Fulton, 2008). The first four papers rely on instrumental 
variables to identify the effect of social capital while the last one exploits panel data and 
introduce individual fixed effects to control for unobservable heterogeneity. 
4. Data 
Data are from the British Household Panel Survey (BHPS) where information on both individual 
trust and health is included in the waves of 1999, 2001, 2004, 2006, 2008.  About 12,000 people 
have been interviewed in each wave: more than 90 percent have been contacted in at least two 
waves, and 37% have been interviewed in all the waves between 1999 and 2008, i.e. about 4,900 
individuals. The time span covered by the data is long enough to find some health and social 
capital variation, although especially trust is rather persistent over-time. For instance, among 
individuals observed in all waves, about 50 percent experienced at least one variation in their 
reported trust overtime, and 30 percent 2 or more variations. 
Social capital is measured by the reported level of generalized trust, an indicator widely used in 
the literature on social capital and health8. The use of this indicator has been  theoretically 
supported by Guiso et al. (2011) given that it can be readily assimilated to a belief about people 
willingness to cooperate. In the BHPS, respondents are asked: “Generally speaking, would you 
say that most people can be trusted, or that you can't be too careful in dealing with people?”. 
They can choose between “Most people can be trusted” or “Can't be too careful”. Our measure 
of trust is then a dummy variable taking on 1 when people answer “Most people can be 
trusted”.9  
                                                            
8 Borgonovi, 2010; D’Hombres et al, 2010; Giordano and Lingstrom, 2010; Hurtado et al, 2011; Mansyur, 
2008; Petrou and Kubek, 2008; Portinga, 2006b; Rostila, 2007; Snelgove et al, 2009; Giordano and 
Lindstrom (2010,2011) just to mention few contributions. 
9 BHPS includes other potential measures of social capital, such as (active) membership to formal and 
informal social organization, that I have chosen to not consider in this paper for a number of reasons: first, 
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In all waves, people are also asked to report the presence or absence of 13 specific health 
problems: 1) Problems or disability connected with: arms, legs, hands, feet, back, or neck 
(including arthritis and rheumatism); 2) Difficulty in seeing (other than needing glasses to read 
normal size print); 3) Difficulty in hearing; 4) Skin conditions/allergies; 5) Chest/breathing 
problems, asthma, bronchitis; 6) Heart/blood pressure or blood circulation problems; 7) 
Stomach/liver/kidneys or digestive problems; 8) Diabetes; 9) Anxiety, depression or bad nerves; 
10) Alcohol or drug related problems; 11)  Epilepsy; 12) Migraine or frequent headaches; 13) 
Other health problems.  
Moreover very detailed information about education, employment condition and type of 
occupation, marital status, region of residence, income, financial situation and number of 
accidents experienced are included. 
Only residents in England  are retained, excluding Wales, Scotland and Northern Ireland, in order 
to increase the cultural homogeneity and limit problems of reporting heterogeneity in 
generalized trust. Moreover and more importantly, the analysis focuses on the initially healthy 
people, defined as those reporting no health problem when they first enter into the dataset. 
This is to eliminate a kind of problematic left censoring: the health history prior to the observed 
time window (between 1999 and 2008) might have influenced initial level of social capital  in a 
way that cannot be account for given that social capital is not reported prior to 1999. In other 
words, initial social capital could not be considered as pre-determined for people entering in the 
observation period with some ongoing disease. Conversely, initially healthy individuals are 
homogenous in the sense that their initial level of social capital differs only for exogenous 
reasons other than their past health history.  
Furthermore, only individuals included in the last three to five waves are selected, in order to 
have enough time variation within individual. Eventually, the sample is composed of about 2100 
individuals. Summary statistics of some key variables are reported in Table 1. In the final sample 
average age is 45 and for about 90 percent of the observations age is below 66. Thus, 
unsurprisingly, the largest majority of the individuals in our sample, 78 percent, is formally 
                                                            
they are conceptually less well founded than generalized trust, since they are more an outcome of social 
capital than social capital itself; second, they are more prone to reverse causation since individual social 
life likely responds more to health, compared to a belief that is grounded on long years of experience and 
is typically quite persistent; third these information are available only for a subset of waves  so that 
estimates obtained by using generalized trust and those adopting alternative measures of social capital 
would not be fully comparable (active membership to formal and informal social organization would be 
available in 2004, 2006 and 2008). 
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employed. About 55 percent attained a upper secondary degree and about 28 percent a higher 
education degree10.  
Eleven diseases (out of 13) are retained: “Epilepsy” and “Alcohol or drug related problems” have 
been pooled to the residual category “Other health problems” because very few people in the 
sample report of suffering from them. The prevalence of each disease is indicated in Table 2. 
Note that for most diseases the prevalence is rather low. This is unsurprising in a sample of 
initially healthy people. Nevertheless, on average, each respondent reports the occurrence of 
about one disease within the ten years between 1999 and 2008 and about one quarter report 2 
or more diseases.   
[Table 1 ABOUT HERE] 
[Table 2 ABOUT HERE] 
 
5. Identification Strategy 
Two problems, unobserved heterogeneity and reverse causation, make the identification of the 
influence of social capital on health difficult to achieve. Unobserved heterogeneity refers to the 
fact that unobservable variables such as individual preferences or family background might 
determine both social capital and health. Recently, Guiso and al. (2008a) have argued that 
individual beliefs about the trustworthiness of other person are transmitted from generation to 
generation in the household. At the same time the recently growing literature on endogenous 
preferences suggests that other traits of individual preferences, such as patience and (likely) risk 
aversion are taught by parents (Doepke and Zilibotti, 2005). Indeed family background 
contributes to both individual social capital and, by influencing sons’ preferences, alters sons’ 
decisions about their health.  
Reverse causation arises because not only social capital could influence health, but also health 
could influence social capital. For instance, sick or disabled people might have less intense social 
interactions and then have less opportunities to update their believes about others’ 
trustworthiness (Guiso et al. 2008a). Also social capital reporting could be altered by health, as 
health is likely to influence the mood of the respondents.  
                                                            
10 While education is predetermined for individuals in our sample and does not vary between 1999 and 
2008, the occupational status may change along ten years considered for a non-negligible proportion of 
individuals.   
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Both phenomena tend to produce positive spurious correlation between social capital and 
health. Therefore simple regression analysis that estimate associations would yield too 
optimistic results. 
This paper proposes an identification strategy that inspires to duration/survival analysis but that 
aims to bypass the difficulties that duration models face to properly deal with unobserved 
heterogeneity and time-varying explanatory variables (see Cameron and Trivedi, 2005, chapters 
17 and 18 ; Hosmer and Lemeshow, 1999, p.248 )11. 
Summarizing, the proposed empirical strategy, alike duration models, exploits transitions from 
a status to another, i.e. from the healthy status to a disease status. However, different from 
duration models, which are based on the probability that transition occurs at any given time, 
here only the occurrence or absence of a transition matters, while the timing of the transition 
matters only to the extent that it induces variation in the explanatory variables. For each 
individual, many transitions are pooled together by simultaneously looking at multiple 
diseases.12 Identification depends on the fact that the level of individual social capital prevailing 
before each transition varies across transitions. This within-individual variation is thus exploited 
to control for unobservable and time-invariant characteristics (such as the individual generic 
propensity to fall ill, family background and preferences).  The effect of time-varying shocks 
influencing both social capital and health conditions is directly accounted for by a number of 
individual controls. 
To avoid terminological confusion with the duration model framework, that despite similarities 
in the intuition is quite different technically-wise, I have preferred to refer to transitions as 
switching points. Precisely, a switching point is defined as the pair composed by the (possible) 
occurrence of a disease and the level of social capital reported immediately before this 
occurrence.  
                                                            
11 In fact standard duration model might accommodate for unobserved heterogeneity only if the 
individual effect is orthogonal to all the included controls. This is at odds with the literature and the 
evidence suggesting that unobservable individual characteristics such as time-preferences and risk 
aversion are related to social capital (see for instance Rocco and Fumagalli, 2013, on this point).  
Furthermore, duration models are inherently cross-sectional. Controls should be pre-determined at the 
beginning of the observation interval and vary only across individuals to guarantee the assumption of 
strict exogeneity. In principle it is possible to extend the analysis to time-varying controls and panel 
structures and exploit the additional information provided by the over-time variation. However, this is 
quite limited in practice precisely because reverse causation will produce a mechanic violation of the strict 
exogeneity assumption underlying duration analysis (see Cameron and Trivedi, 2005, p.598).  
12 Precisely, I focus exclusively on the first transitions for each considered disease. The possible selection 
concerns arising from using only the first transition are limited by the fact that I am considering long lasting 
and chronic diseases. Particularly, the latter may occur only once and never heal, so that there will exist 
at most one transition from healthy to sick state. 
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The initial panel of individual-year observations is re-arranged into a different panel of 
individual-disease observations. In the latter the outer dimension corresponds to the individual 
identifier (i) and the inner dimension corresponds to the disease identifier (d). Eleven long-
lasting and chronic diseases are considered13 and therefore eleven records, one for each 
possible disease, are associated to each individual. This implies that all observations (the 
statistical units) of the dataset shall be indexed by the pair (i,d). Each observation corresponds 
to a switching point that is codified in two variables, the event variable Pid and the social capital 
indicator Sid. If disease d ever occurred between 1999 and 2008 to individual i, the variable Pid 
takes the value 1. Otherwise it takes zero. Attention is restricted to those individuals who are in 
good health (i.e. that do not report any diseases at the onset of the observation period) to avoid 
that their health history prior to 1999 influence their level of social capital reported in 1999.14 
The second component of the switching point, the variable Sid, collects the level of social capital 
declared by individual i (in the wave of data) before the occurrence of disease d. By construction, 
social capital is then pre-determined with respect to disease d, a feature that reduces concerns 
of endogeneity.  
Eventually, two vectors Pid and Sid , collecting all possible switching points, are obtained after 
data reshaping. Note that the time dimension is left implicit by this representation, but it 
crucially determines within-individual variation in Sid.15  
Figure 1 helps to clarify how switching points are defined. The Figure represents the situation of 
a hypothetical individual, initially healthy, observed five times, denoted from t0 to t4, at regular 
intervals, along a period of given and fixed length.  Suppose for simplicity that there exist 
information about five diseases, from D1 to D5, where D5 is a residual category encompassing 
all other diseases excepting D1, D2, D3 and D4. The timing of the first occurrence of a disease is 
indicated by a triangle. If a disease never occurs between t0 and t4 a star is marked at t0. Next, 
the occurrence of each disease is associated with the level of individual social capital at the time 
just preceding the disease onset. In the Figure circles indicate the timing at which these 
information is collected.16 If a disease does not occur, the considered level of social capital is 
that reported at time t0. For any disease, the combination of one triangle (or star) and one circle 
                                                            
13 Short-term and recurrent diseases are excluded because it is unlikely they have permanent effects on 
social capital. Recall that one disease is residual and it is defined as “other diseases”. 
14 Concerns relative to possible sample-selection resulting from the decision of looking only at the initially-
healthy people are largely mitigated by the inclusion of individual fixed effects, which account for the 
time-invariant characteristics which are associated with selection into the sample.   
15 In the present context fixed effect models that rest only on overtime variation for identification, are of 
little utility since social capital is very persistent overtime for any given individual.   
16 Also other relevant time-varying information, such as his/her income, kind of occupation and marital 
status are collected at this timing. 
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graphically identify the timing of a switching point, i.e. the timing at which an individual 
condition changes (a disease before absent has now occurred) and the timing at which the 
information about individual social capital is collected. 
On the reshaped data, the following empirical model is estimated    
𝑃𝑃𝑖𝑖𝑖𝑖 = 𝛼𝛼0 + 𝛼𝛼1𝑆𝑆𝑖𝑖𝑖𝑖 + 𝛼𝛼2𝑆𝑆𝑖𝑖𝑖𝑖 ∗ 𝛿𝛿𝑖𝑖 + 𝛼𝛼3𝑋𝑋𝑖𝑖𝑖𝑖 + 𝜇𝜇𝑖𝑖 + 𝛿𝛿𝑖𝑖 + 𝜀𝜀𝑖𝑖𝑖𝑖       𝑖𝑖 = 1, … ,𝑁𝑁;    𝑑𝑑 = 1, … ,11 
where 𝑃𝑃𝑖𝑖𝑖𝑖  is the indicator variable which captures the possible occurrence of disease d to 
individual i, and  𝑆𝑆𝑖𝑖𝑖𝑖  and  𝑋𝑋𝑖𝑖𝑖𝑖 are the levels of individual i’s social capital and other relevant 
time-varying characteristics declared before the occurrence of disease d. Specificities in the 
effect of social capital across diseases are captured by a full set of interactions between social 
capital and disease-specific dummies 𝑆𝑆𝑖𝑖𝑖𝑖 ∗ 𝛿𝛿𝑖𝑖. Therefore the marginal effect of social capital on 
the probability that disease d occurs is given by 𝛼𝛼1 + 𝛼𝛼2 ∗ 𝛿𝛿𝑖𝑖. Individual fixed effects 𝜇𝜇𝑖𝑖 are 
included to control for all time-invariant and individual-specific features, which can be 
correlated with both social capital and health, and, finally, a full set of disease dummies 𝛿𝛿𝑖𝑖 are 
included to control for disease-specific prevalence rates. The error term 𝜀𝜀𝑖𝑖𝑖𝑖 is allowed to be 
clustered at individual level.   
Individual controls included in Xid are time-varying and, particularly, they are evaluated at the 
time of the switching point. They are: the number of accidents occurred since 1997, employment 
condition and type of occupation, log of household annual income, marital status, and region of 
residence17. These controls account for possible time-varying shocks which might 
simultaneously influence social capital and health. For instance variation in the marital status 
accounts for partner’s death or separation. Variation is the region of residence dummies, in 
employment condition and occupation account for other shocks important to individual social 
life and health.     
A complication that we have not discussed yet is the possible interdependence between 
switching points. The first insurgence of a particular disease, especially if hampering social 
relations (such as sight and hearing problems), likely slows down the subsequent process of 
social capital accumulation and in turn influences the likelihood that other diseases occur in the 
future18. For instance in Figure 1, the occurrence of D1 at time t2 might alter the 
contemporaneous level of social capital that is associated to the occurrence of D3. Treating 
                                                            
17 Of course, individual fixed effect account for all individual time-invariant characteristics, such as gender, 
the age when they entered our dataset and predetermined variables, such as schooling that does not vary 
among adult people.   
18 Moreover, some diseases might be complications of previously developed chronic conditions. For 
instance the probability of eyesight, heart or kidney problems is larger among the diabetics.    
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observations D1 and D3 as independent rather than part of unique process could then be 
misleading.19 To avoid this problem, an alternative procedure, illustrated in Figure 2, is worth 
considering. If two diseases occur, say, at time t2 and t3, the level of individual social capital 
(and other factors) to be recorded is that reported at time t=min(t2,t3)-1=t1. More generally the 
relevant timing to consider is that of the onset of the fist disease, whatever the number of 
diseases occurred in the period of time considered.   
In what follows, Specification 1 will refer to the procedure corresponding to Figure 1 and 
Specification 2 to that corresponding to Figure 2.  
Compared to Specification 1, Specification 2 modifies only the way information reported by 
individuals experiencing two or more diseases is codified in the switching points: these people 
count for  less than one quarter of the sample.      
 [Figure 1 ABOUT HERE] 
[Figure 2 ABOUT HERE] 
 
6. Results 
Model (1) is estimated by means of an individual fixed-effect linear probability model. Estimates 
of the parameters associated to Sid and Sid*δd  are reported in Table 3 (to save space all 
remaining controls have been omitted from the table). Columns 1-3 refer to Specification 1 and 
columns 4-6 refer to Specification 2. Columns 1 and 4 report the estimates of the basic model 
omitting controls Xid, while in columns 2 and 5 controls are included. Finally in columns 3 and 6 
the model has been restricted to the subset of chronic diseases (breathing, heart, diabetes, sight 
and hearing problems). Although focusing on chronic diseases is interesting per se, the main 
purpose of this restriction is that of shedding further light on the role played by Specification 2. 
By definition, chronic diseases are never-ending. Hence, it is likely that the level of social capital 
reported after their occurrence changes permanently. This is the situation where results 
produced by Specification 2 should differ the most from those of Specification 1.   
                                                            
19 Competing risk models would not be suitable in this context. Indeed they assume “exclusive spells” (see 
Cameron and Trivedi, p.642), that is only one of the risks can actually materialize. After this event, all 
other risks are censored. The typical application is that analyzing the role of different causes of death, 
where people die only once and for only one cause, even if multiple risks are competing to achieve this 
(unfortunate) outcome. In our context instead multiple diseases might coexist. On top of this the problem 
of unobserved heterogeneity would remain unsolved. 
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Estimates indicate that individual trust significantly reduces the probability of occurrence of all 
diseases. The size of the reduction is quite large, around 14-18 percent, varies little across 
specifications and is scarcely influenced by the inclusion or omission of socio-economic controls. 
Although these effects appear quite large, it should be kept in mind that the available measure 
of social capital is dichotomous and implies a comparison between rather extreme level of 
trustfulness (“most people can be trusted” vs “you can’t be too careful”).  
The impact of each disease is similar, as the estimates corresponding to the interactions indicate. 
Only for “hearing problems” and “other problems”, trust has a systematically smaller impact on 
their likelihood. When only chronic diseases are considered, estimates are larger, but only the 
estimates corresponding to Specification 2 (column 6) are significantly larger. This fact indicates 
that the influence of a disease on subsequent social capital level (that is neutralized in 
Specification 2) is sizeable and tends to reduce the magnitude of the effect of trust on the 
probability of experiencing a disease.       
Next, Table 4 shows how results change by considering different population subsets separately. 
The potentially more reliable Specification 2 is adopted and the full set of diseases and controls 
are included. Thus, the benchmark against which to compare estimates of Table 4 is column 5 
of Table 3. Of course the reduced sample size makes more difficult to get precise estimates. 
However looking at the point estimates is informative enough to draw few broad conclusions. 
In column 1 and 2 the model is estimated separately on females and males respectively. 
Although the impact of trust is larger for males, the difference between genders is modest. Next, 
in columns 3 and 4 people aged less than 50 are compared with the over-50. The choice of this 
threshold is motivated by the fact that the fifties are the age at risk for cardiovascular diseases 
and other chronic diseases. Surprisingly, the effect of trust is stronger among the younger, 
although the younger tend to have less social capital than the elderly, as Guiso et al. (2008a) 
have shown, and as it is the case also in our sample (37 percent of the of the younger declare to 
trust others compared to 51 percent of the aged 50+).    
Moving to the level of education, columns 5 and 6, people with a university degree enjoy higher 
returns of social capital than the less educated. Typically, they have larger social networks and 
so more opportunities for social capital to display its beneficial influences. Indeed the more 
educated people tend to report much more trust than the less educated (59 percent compared 
to 39 percent).  
Finally in columns 7 and 8 the residents in regions with average levels of trust below the median 
(0.44) are contrasted with those residing in regions above the median. The impact of trust is 
larger for people residing in areas richer of social capital. This result indicates that individual and 
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community social capital are indeed complements, consistently with Guiso et al.’s theory of 
social capital. Social capital is not an asset which can be used in isolation, as it could be for 
instance human capital. Individual social capital produces positive consequences only in a 
favorable social environment.  
[Table 3 ABOUT HERE] 
 
[Table 4  ABOUT HERE] 
 
 
 
7. Conclusions 
This paper provides additional evidence in favor of a positive relationship between social capital 
and health. So far the largest part of the literature has looked at self-reported indicators of 
general health and only recently it has paid attention to the issues of unobserved heterogeneity 
and reverse causation. The contribution of this paper is twofold. First, it adopts as health 
outcomes the more objective occurrence of specific diseases within a time window of about ten 
years. This strategy allows to isolate the effect of social capital on “true” health from the effect 
on the individual assessment and reporting of health. Second, the paper suggests a previously 
overlooked strategy to avoid reverse causation and to account for unobserved individual 
heterogeneity. Evidence of a strong causal beneficial effect of social capital has emerged: 
individuals who declare that “most people can be trusted” are about 14 to 18 percent less likely 
to incur in any disease, establishing that social capital does influence “true” health and not only 
how health is assessed and reported by the individuals. Results are robust to two alternative 
specifications and to the inclusion or omission of individual socio-economic controls. 
Furthermore, the effect of social capital appears to be larger among the younger, the more 
educated and among those living in regions richer in social capital.   
Estimates also indicate that trust affects the likelihood of all diseases to a similar extent. The 
latter result suggests that social capital does not enter into the medical etiology specific to each 
disease, but rather that it modifies the generic propensity of an individual to fall ill. This 
interpretation fits well with the mechanisms, mentioned in the introduction, that explain the 
link between social capital and general health. Indeed, all these mechanisms influence the socio-
economic context where people live, creating conditions favorable to health protection. For 
instance, social capital favors the diffusion of health-relevant information and the creation of 
social safety nets, discourages all risky behaviors by increasing their opportunity costs, favors 
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political cohesion in a community allowing for a larger influence in the repartition of the national 
resources devoted to public health.  
Several limitations of the current study can be mentioned. The most important is that there are 
no other suitable measures of social capital in the dataset at use. This prevents to check the 
robustness of our estimates by using alternative indicators equally consistent with Guiso et al. 
definition of social capital. The second limitation is that, given the timing of data collection of 
BHPS, social capital is observed two years before the occurrence of the corresponding disease, 
while the optimal timing would be immediately before the occurrence of the disease. Hence the 
social capital indicator could be affected by an error-in-variable. The third limitation is that the 
time span covered by data is at most 10 years and in some cases just 8 or even 6 years. Thus, 
given the high persistence of social capital, the number of available switching points for each 
individual is rather small, a feature that reduces estimates precision (as it is particularly apparent 
in the analysis carried over smaller samples). Another limitation is the fact that the presence or 
absence of a disease is declared by the respondents and might be influenced by individual 
education and socioeconomic status. Indeed, typically, the more educated and the better off 
are more aware of their health conditions. Also the trust variable is not without potential 
drawbacks. First, generalized trust is dichotomous, implying smaller variation and imprecise 
correspondence with the latent degree of trustfulness which is likely to be continuous. Second, 
generalized trust is self-reported and subject to mis-reporting.  Deviations in reporting might 
depend, for instance, on respondents’ willingness to please the interviewer.    
Undoubtedly, further research is necessary in this field and, particularly, better data are 
necessary to get more reliable results, although the evidence published in the recent years is 
almost unanimous in pointing to the existence of a positive causal influence of social capital on 
health.  
This paper contributes to the view that social factors do play an important role in shaping 
individual health conditions, a role perhaps overlooked by health policy so far. 
It is widely acknowledged that education and income cannot be the only cause for differences 
in mortality and morbidity and that other social factors contribute to individual health and 
health inequality. Already Marmot and Wilkinson in their seminal book (Marmot and Wilkinson, 
2005) included social support, social cohesion and social exclusion among the social 
determinants of health. Conceptually, social capital is at the root of many social determinants, 
and particularly social cohesion and social support. 
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However, social capital, as far as it is defined as an individual attitude to cooperate or an 
individual belief about others’ willingness to cooperate, is largely outside the reach of 
governments, which can do little to increase the stock of social capital in the society, at least in 
the short run, because beliefs are highly persistent and, according to Guiso et al. (2007, 2008a), 
they are updated only after a long period of experienced cooperation.  
Governments have a role in promoting the rule-of-law, a condition that certainly induce 
individuals to expect cooperation from their partners in the domain of formalized relationships, 
such as contracts and economic transactions. It is much less obvious that rule-of-law might play 
a role in the domain of informal relationships, which is crucial for the pathways through which 
social capital benefits health. Take for instance information diffusion, or informal support in case 
of need: these mechanisms are typically informal and do not respond to government legislation.   
Nevertheless, governments can certainly favor the deployment of social capital’s beneficial 
effects. For instance, they could support the operations of informal safety nets by promoting 
more flexible working time, by supporting voluntary activities, or by permitting that someone 
outside the circle of strict relatives might go to see a hospitalized person beyond visiting hours 
and obtain reserved information from the hospital and the doctors if properly authorized.      
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Figure 1 – Specification 1 
 
Legend: D1-D5 indicate diseases; t0-t1 indicate points in time; triangles indicate the first 
occurrence of the disease reported on the horizontal axis; stars indicate that the 
corresponding disease on the horizontal axis has never occurred in the period between t0 and 
t4; finally, circles indicate the time at which information on individual social capital and other 
controls is collected for each possible disease.    
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Figure 2 – Specification 2 
 
Legend: see Figure 1 
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 Table 1 – Summary statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: (*) dummy variable 
 
 
Table 2 – Disease Occurrence 
diseases never occurred occurred total 
anxiety 1,953 179 2,132  
arms-legs 1,558 580 2,138  
breathing 1,959 174 2,133  
diabetes 2,085 49 2,134  
hearing 2,020 114 2,134  
heart 1,859 277 2,136  
migraine 1,975 164 2,139  
others 1,978 156 2,134  
sight 2,035 99 2,134  
skin 1,887 249 2,136  
stomach 1,990 146 2,136  
 
variable mean std. 
dev. 
min max 
number of diseases reported between 
1999 and 2008 
1.000 1.191 0 9 
trust* 0.424 0.487 0 1 
age 45.480 15.107 21 90 
log annual income 8.645 2.119 1.098 12.291 
number accidents since 1997 0.112 0.355 0 3 
married* 0.512 0.497 0 1 
employer, manager, or self-
employed* 
0.148 0.350 0 1 
non manual worker* 0.382 0.478 0 1 
manual worker* 0.205 0.398 0 1 
own account worker* 0.039 0.191 0 1 
agricultural worker* 0.006 0.078 0 1 
non employed* 0.220 0.407 0 1 
female* 0.485 0.500 0 1 
higher education* 0.278 0.448 0 1 
upper secondary education* 0.556 0.497 0 1 
23 
 
Table 3. Baseline Estimates. The effect of trust on the probability that a disease occurs. 
 Specification 1 Specification 2 
VARIABLES w/o controls with controls chronic diseases w/o controls with controls chronic diseases 
 baseline: anxiety baseline: anxiety baseline: breathing baseline: anxiety baseline: anxiety baseline: breathing 
       
trust -0.143** -0.165*** -0.190** -0.166* -0.178** -0.247** 
 (0.0596) (0.0574) (0.0809) (0.0859) (0.0823) (0.118) 
trust*armslesgs -0.0116 -0.0182  -0.00196 -0.00498  
 (0.0214) (0.0211)  (0.0210) (0.0205)  
trust*breathing 0.00813 0.00349  0.0204 0.0185  
 (0.0158) (0.0154)  (0.0160) (0.0154)  
trust*diabetes 0.0246* 0.0181 0.0128 0.0238* 0.0194 -0.000568 
 (0.0129) (0.0128) (0.0119) (0.0131) (0.0127) (0.0123) 
trust*hearing 0.0396*** 0.0322** 0.0279** 0.0436*** 0.0407*** 0.0223 
 (0.0148) (0.0146) (0.0137) (0.0153) (0.0149) (0.0141) 
trust*heart 0.0266 0.0228 0.0192 0.0342* 0.0322* 0.0109 
 (0.0176) (0.0171) (0.0162) (0.0178) (0.0173) (0.0165) 
trust*migraine 0.00861 0.00507  0.00800 0.00617  
 (0.0148) (0.0147)  (0.0149) (0.0145)  
trust*others 0.0434*** 0.0348** 0.0298** 0.0384** 0.0346** 0.0146 
 (0.0157) (0.0153) (0.0145) (0.0154) (0.0148) (0.0148) 
trust*sight 0.0210 0.0158  0.0291** 0.0231  
 (0.0140) (0.0138)  (0.0145) (0.0142)  
trust*skin 0.0326* 0.0252  0.0320* 0.0300*  
 (0.0170) (0.0164)  (0.0173) (0.0166)  
trust*stomach 0.0173 0.0143  0.0269* 0.0252*  
 (0.0154) (0.0151)  (0.0155) (0.0150)  
       
Observations 23490 23490 10672 23486 23486 10671 
R-squared 0.058 0.107 0.080 0.057 0.100 0.077 
Number of individuals 2160 2160 2141 2153 2153 2139 
Note: Robust standard errors in parentheses, clustered by individual *** p<0.01, ** p<0.05, * p<0.1 
Individual fixed effect linear probability model estimates. The dependent variable is occurrence of a disease (1 occurred / 0 never occurred between 1999 and 2008). Regressions include the social capital variable (trust) and its 
interactions with each disease (reported in the table) and control for the number of accidents occurred since 1997, employment condition and type of occupation dummies,  log of household annual income, marital status, region 
of residence dummies and diseases-specific dummies (non reported). Columns 1-3 refer to Specification 1 and columns 4-6 to Specification 2. In columns 1 and 4 controls are omitted. In columns 3 and 6 only chronic diseases 
are retained. 
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Table 4. Estimates separately by socio-economic conditions. The effect of trust on the probability that a disease occurs. 
 By gender By age By education By place of residence 
VARIABLES female male younger than 50 older than 50 higher education lower education below median 
 gen. trust 
above median 
 gen. trust 
 (1) (2) (3) (4) (5) (6) (7) (8) 
         
trust -0.145 -0.187 -0.247** -0.0214 -0.377** -0.124 -0.180 -0.250* 
 (0.114) (0.118) (0.101) (0.122) (0.169) (0.110) (0.139) (0.130) 
trust*armslesgs -0.0271 0.0108 0.00583 -0.0897** 0.0493 0.0263 -0.0211 0.0344 
 (0.0307) (0.0272) (0.0224) (0.0382) (0.0340) (0.0269) (0.0299) (0.0261) 
trust*breathing 0.0124 0.0187 0.0187 0.00306 0.0253 0.0632*** 0.0122 0.0242 
 (0.0244) (0.0190) (0.0168) (0.0295) (0.0305) (0.0195) (0.0213) (0.0203) 
trust*diabetes 0.0192 0.0130 0.0307** -0.00271 0.0536** 0.0307* 0.0257 0.0135 
 (0.0203) (0.0152) (0.0137) (0.0248) (0.0266) (0.0158) (0.0162) (0.0175) 
trust*hearing 0.0430* 0.0321* 0.0330** 0.0321 0.0735*** 0.0557*** 0.0548*** 0.0309 
 (0.0233) (0.0185) (0.0144) (0.0304) (0.0273) (0.0187) (0.0204) (0.0197) 
trust*heart 0.0268 0.0319 0.00894 -0.000564 0.0546* 0.0764*** 0.0261 0.0252 
 (0.0271) (0.0216) (0.0157) (0.0355) (0.0309) (0.0225) (0.0237) (0.0226) 
trust*migraine -0.00202 0.0109 0.0121 0.00193 0.0489* 0.00365 0.0267 0.00201 
 (0.0248) (0.0158) (0.0173) (0.0253) (0.0267) (0.0187) (0.0203) (0.0186) 
trust*others 0.0490* 0.0209 0.0256 0.0382 0.0259 0.0409** 0.0383** 0.0329* 
 (0.0251) (0.0163) (0.0163) (0.0281) (0.0317) (0.0183) (0.0190) (0.0199) 
trust*sight 0.00584 0.0334* 0.0345** 0.000746 0.0449* 0.0395** 0.0289 0.0157 
 (0.0225) (0.0172) (0.0157) (0.0265) (0.0264) (0.0176) (0.0199) (0.0186) 
trust*skin 0.0147 0.0398* 0.0378* 0.0332 0.0838** 0.0200 0.0650*** -0.00600 
 (0.0265) (0.0203) (0.0201) (0.0282) (0.0346) (0.0210) (0.0246) (0.0207) 
trust*stomach 0.0222 0.0231 0.0284 0.0154 0.0402 0.0489** 0.0414* 0.0109 
 (0.0239) (0.0180) (0.0173) (0.0274) (0.0283) (0.0198) (0.0214) (0.0193) 
         
Observations 11353 12133 14966 8520 5338 13826 11332 12154 
R-squared 0.098 0.121 0.147 0.138 0.198 0.117 0.107 0.092 
Number of  
individuals 
1043 1110 1372 781 491 1265 1142 1185 
Note: Robust standard errors in parentheses, clustered by individual *** p<0.01, ** p<0.05, * p<0.1 
Individual fixed effect linear probability models estimated separately on sub-samples indicated in each column head. All estimates are obtained by adopting Specification 2 with controls included (see note Table 3). Baseline 
disease is anxiety. 
 
